H-00848-2001.R1 3

Main text:
Experimental myocardial infarction (MI) decreases left ventricular pumping ability by impairing both systolic and diastolic function. The absence of contractility in the infarcted region translates as a hemodynamic stress exerted on the scar tissue during systole [1, 2] . Formerly thought to be inert, experiments show that the fibrous scar is a dynamic remodelling tissue [3] responding to systolic hemodynamic forces, which perhaps plays an active role not only in its own scarification, but also in that of the remaining myocardium [4] . In parallel, increase in left ventricular diastolic pressure has some early upstream consequences on the pulmonary circulation including increase in pressure and vascular dimensions and decrease in endothelial shear stress [5] . This decrease in shear stress on pulmonary endothelium leads to some endothelial dysfunction such as decrease in eNO synthase expression [5] and increase in endothelin secretion [6] .
Angiotensin Converting Enzyme (ACE) is a ubiquitous ectoenzyme responsible for the conversion of the inactive angiotensin I (AngI) to the active AngII, an important mediator of myocardial and vascular remodelling. Inhibition of ACE has proven to be effective in decreasing mortality [7] and preventing remodelling [8, 9] in myocardial infarction. ACE is an integral transmembrane protein, present also in the plasma in a solubilized form, shed by a zinc metalloprotease that cleaves the membrane bound form in the stalk region [10, 11] . In physiological conditions, the pulmonary endothelium is considered to be the main source of the plasma solubilized ACE [12] . Nevertheless, in pathological conditions ACE gene expression can shift from a predominant and constitutive endothelial expression to a more inducible expression in non endothelial cells, providing evidence of cell activation including smooth muscle cells and fibroblasts in response to hemodynamic forces [13] [14] [15] and monocytes during macrophage transformation [16] . In a previous study we showed a decrease in ACE expression in the lung and an increase in its plasma concentration correlated with the severity of myocardial infarction-induced heart failure in rats [17] .
Moreover the presence of ACE in the scar [18, 19] mainly expressed by myofibroblasts [20] has been previously documented by in situ approaches.
In the present study we further investigated the discrepancy between pulmonary and plasma ACE in heart failure in rats. We hypothesized that the increase in plasma ACE could be the result of a shift in ACE expression from the pulmonary endothelium to the scar and that the phenomenon of shedding could be responsible for the increased H-00848-2001.R1 4 plasma ACE. We therefore examined ACE activity both in the tissues as well as in the supernatant of tissue explants, allowing us to investigate the shedding, and compared ACE mRNA expression in the lung and scar, permitting us to explore the shift from a physiological to a pathological site of expression. Results were compared not only between MI and sham rats, but also between the two basic classifications of MI rats; compensated and decompensated, the latter representing rats with a greater infarct severity.
METHODS
Experimental Design
Normotensive male Wistar rats (CERJ) were used. Rats were housed in a temperature and humidity controlled environment on a 12h/12h light/dark cycle. Rats were fed standard rat chow and water ad libitum. Myocardial infarction of the left ventricle (LV) was obtained by ligature of the left descending coronary artery under general anesthesia (1 ml/kg Ketamine (Imalgène 500, Merial) and 0.5 ml/kg Xylazine (Rompun 2%, Bayer) intraperitoneally) and positive pressure ventilation as described by Fishbein et al [21] . Sham operated rats underwent the same surgical procedure with the exception of coronary ligature. Rats were examined by echocardiography during the week preceding the sacrifice. After three months all animals were sacrificed under heavy anesthesia by sodium pentobarbital 6% (70 mg/kg, Sanofi). The experimental protocol is in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institute of Health (NIH publication No. 85-23, revised 1996) and performed under the authorization of the French Accreditation of Laboratory Animal Care (authorization N° 00577).
Blood was collected in 10ml prechilled tubes on citrate (11mM) and the plasma separated by centrifugation at 2500g for 10 minutes at 4°C and frozen at -20°C until used. Lung tissue was either immediately frozen in liquid nitrogen for mRNA analysis or put into sterile 15ml polypropylene tubes containing 2ml sterile RPMI (without Methionine or Glutamine, Bio Media) for subsequent incubation. The heart was excised and weighed. The left ventricle (LV) was removed and the scar (in infarcted rats) carefully separated. Both were weighed and either frozen in liquid nitrogen or collected in sterile 15ml polypropelene tubes as described above.
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Echocardiographic analysis
Echocardiography was performed one week prior to sacrifice using a commercially available echographic system (Toshiba 6000, SSA 370A) equipped with a 14 MHz linear probe. Rats were lightly anesthetized by inhaled isoflurane, the chest shaved and the animals placed in the supine position. Electrocardiographic electrodes were placed on inferior legs and on the neck for timing of intracardiac events by use of the single-channel electrocardiogram available on the imaging system. The interrogation depth was set at 3 cm.
Two-dimentional echocardiography. Left ventricle (LV) was imaged in both parasternal long axis and short axis views at a frame rate of 120 Hz and transferred online to a computer as dynamic loops of 50 frames, allowing for off-line analysis (Ultrasound Image Workstation-300A, Toshiba). End-diastolic area was defined as the largest left ventricular area and end-systolic as the smallest. Ejection fraction was calculated off-line by the modified Simpson's method.
M-mode tracings were recorded at the level of the papillary muscles and aortic valves with two-dimensional image guidance. LV and left atrial (LA) cavity diameters were measured according to the recommendations of the American Society of Echocardiography [22] .
Interobserver reproductibility of echographic parameters was assessed in all rats. Variability was expressed as the mean percent error, derived as the absolute difference between the two measurements divided by the mean of the measurements (Table 1) .
Tissue Explant Incubation
Incubation of tissue explants was performed under sterile conditions in FB 24 plaques containing 1ml colorless RPMI with 1% PSA and 2% HEPES. Incubation lasted 24h at 37°C, 5% CO 2 . Supernatants were centrifuged H-00848-2001.R1 6 (1000g for 15 minutes) and frozen at -20°C until used. The tissues were weighed and frozen at -20°C.
Infarct Size Determination
The scar's surface area was determined by tracing its circumference on millimeter graph paper, which was then cut and weighed [23] .
Evaluation of mRNA expression by RT-PCR
Total RNA was extracted from LV, lung and scar tissues using the method described by Chomczynski and Sacchi [24] . RNA was quantified by optical density at 260 nm. Samples were migrated by electrophoresis (80 mV) to control the quality of the extracted RNA. For reverse transcription, 1µg of mRNA was used for the LV and scar and staining. The bands were cut and digested with periodic acid at 25mM for 2 hours at 50°C and counted with a RackBeta scintillation counter after addition of a scintillation solution (OptiPhase 'HiSafe' 3, Wallac). PCR amplification was verified to be exponential, and the amplification products were proportional to sample input.
ACE mRNA expression was calculated by normalizing with respect to GAPDH mRNA expression.
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ACE activity determination
Plasma and explant supernatants were tested directly whereas an extraction was performed on tissues. Tissues were homogenized in TrisHCL (pH = 7.4) by potterisation and subsequently centrifuged at 1000g for 10 minutes at 4°C.
The supernatant was collected and centrifuged at 15000g for 10 minutes at 4°C. The supernatant was discarded and the pellet redissolved in 1ml Tris-HCL with 8.5 mM Chaps (no Chaps was added for the lung tissue). Samples were sonificated for 20 seconds before being used.
The fluorometric assay protocol was based on the technique described by Freidland and Silverstein [25] . Samples were incubated for 10 to 60 minutes at 37°C in the presence of Z-PHL (Z-Phe-His-Leu-OH, Bachem), and Na- Some tissue explants were incubated in the presence of GM 6001 (Calbiochem), a non-specific metalloprotease inhibitor previously shown to prevent shedding of other integral membrane proteins [26, 27] . Previous experiments in our laboratory indicated that a concentration of 1mM GM 6001 inhibited the apparition of ACE activity in the explant supernatant, while not affecting ACE activity itself. These incubations were performed under the same conditions as previously described.
ACE activity in the tissue explant supernatants was normalized with respect to the total protein content in the incubated explant for the lung and total protein in the supernatant for the LV and scar, and in the tissues with respect to total protein (assayed using BioRad total protein assay).
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Run-on Assay
The transcription rate of the ACE gene was determined by a run-on assay as previously performed in the laboratory [28] . Lung nuclei were isolated at 4°C as described by Boggaram et al [29] . In vitro transcriptions were carried out in the presence of 4 x 10 7 isolated nuclei and (α-32 P)CTP, as described by Mak et al with slight modifications .
cDNA (10 µg) encoding for ACE and GAPDH, amplified in Bluescript KS plasmids and pGEM plasmids respectively, were denatured and immobilized on a nylon filter (Hybond-N, Amersham). Empty plasmids were used as negative controls. Slot blots were then hybridized with equivalent amounts of radioactive RNA (7 x 10 6 cpm) obtained from lungs of myocardial rats or control rats. Following hybridization, the blots were washed and exposed to Kodak Biomax MS film with an intensifying screen at -80°C for 7 days. The intensity of the band is proportional to the in vitro transcription rate.
Statistical Analysis
All results are expressed as the mean plus or minus SEM. The statistics package StatView 4.0 was used to calculate one-way ANOVAs for the comparison of biological parameters between the three experimental groups, post-hoc Scheffe tests and regression analyses. All tests used an alpha of 5%. Statistical significance was recognized when p < 0.05.
RESULTS
A total of 65 rats were used of which 44 underwent coronary ligature. The operation created 27 rats who were classified as compensated, and 17 as decompensated. Decompensated rats were identified as those presenting a pleural effusion. This classification was confirmed by echocardiography (see below). One half of the rats were exploited for mRNA analysis and the other half for explant incubation.
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Heart parameters
There was a slight tendency towards a reduction in body weight (BW) in rats with MI, which remained nonsignificant (536.0 ± 14 in sham, 516.7 ± 11 in compensated, 493 ± 15 g in decompensated rats). Heart weight increased with respect to infarct severity (1.58 ± 0.03 in sham, 1.66 ± 0.04 in compensated and 2.13 ± 0.07 g in decompensated rats, p < 0.0001). In addition to the presence of pleural effusion, the classification of the rats as being compensated or decompensated was confirmed by an increase in right heart weight (heart weight-LV weight)/BW(body weight) ratio [2] , scar surface area, LVEDD (Left Ventricular End Diastolic Diameter)/BW [2, 31, 32] and left atrial diameter [33] , and a decrease in the EF (ejection fraction) [33] ( Table 2) .
ACE mRNA expression
The expression of ACE mRNA in the lung decreased significantly 
ACE gene transcription
Run-on experiments were performed in order to measure the transcription rate of the ACE gene in the lung tissue. Transcription rate of ACE in the lung, normalized with respect to that of the GAPDH gene was (Figure 4 ). In the LV, ACE activity was below detection limits.
Tissue explants were incubated in serum-free culture medium for 24 hours at 37°C. For scar and LV explants, the ACE activity in the culture supernatant was normalized with respect to the total protein in the culture supernatant.
Due to the edema present in the congestive heart failure lung, the ACE activity in the lung supernatant was 
Inhibition of ACE shedding
In order to determine whether or not the secretion of ACE into the tissue culture supernatants was the result of specific enzyme activity, we incubated lung, LV and scar tissue in the presence of GM 6001, a non-specific metalloprotease inhibitor. In the presence of 1mM GM 6001, ACE activity in the supernatants was almost completely abolished (30.81 ± 3.4 vs. 2.86 ± 1.9 in the lung, 6.71 ± 2.8 vs. 2.3 ± 1.1 in the LV and 42.0 ± 4.0 vs.
5.3 ± 1.4 nmol/mg protein in the scar)( Figure 5 ) whereas ACE activity in the tissues was conserved (data not shown).
Immunohistochemistry
Immunohistochemistry showed a strong ACE staining in the medial portion of the infarct scar.
Immunohistochemistry of ED-1 was negative in the scar and LV (not shown). Immunostaining for α-SMA, a marker of myofibroblasts, showed a central localization within the scar ( Figure 6 ) and was negative in the remaining LV except for the medial layer of coronary arterial vessels (not shown). With the exception of the coronary arteries, this expression was concurrent with that of ACE. Hematoxylin-eosin and Masson trichrome staining show that this expression is also concurrent with the presence of collagen fibres.
DISCUSSION:
The objective of this study was to determine the topology of ACE expression in rats following myocardial infarction and to determine whether or not ACE expression and shedding patterns vary with respect to infarct severity. Three months following MI we measured ACE mRNA expression and activity in lung, infarcted LV (scar) and remaining viable LV. We incubated tissue explants in serum free medium and measured the ACE activity in the supernatants as well as in the plasma in order to ascertain tissue shedding of ACE. Transthoracic echocardiography has been shown as a useful technique for assessing LV remodelling after MI in the rat [31] [32] [33] [34] [35] [36] .
In the present study, the use of highframe rate echocardiography allowed high quality recordings in 2D and Mmode (Fig.1) . Low variability of LVEDD and LA diameter measurements was observed ( [22] . This technique has been previously used in rats [37] . Quality of 2D recordings was good enough to identify LV endocardial borders with an acceptable interobserver reproductibility (Table 1) .
In this study we confirm that plasma ACE activity is increased in experimental MI [17] and this in proportion to the left ventricular dysfunction as demonstrated by the correlation to ejection fraction, LA diameter and LVEDD/BW ratio. We also show that the infarct scar is an important source of ACE. ACE activity in the scar tissue increased, parallel to an increase in ACE mRNA expression. ACE activity in the scar tissue is negatively correlated with ejection fraction, a key indicator of the left ventricular dysfunction. We incubated the scar explants and dosed ACE activity in the culture supernatants in order to determine the shedding of ACE. Solubilized ACE activity increased in proportion to MI severity and with respect to LV systolic dysfunction as indicated by the negative correlation with EF. To ensure that the shedding of ACE into the explant culture medium was due to specific enzyme activity and not simply to tissue sufferance, we incubated the explants in the presence of GM 6001. This inhibitor is a broad range metalloprotease inhibitor [27, 38] which, at the dose used, does not interfere with ACE activity itself. In the presence of GM 6001, ACE activity was no longer detected in the supernatants confirming the role of a metalloproteinase in tissue ACE shedding in vivo.
Previous studies in our laboratory have shown a decrease in lung ACE mRNA expression and tissue ACE activity [17] in experimental heart failure in rats. In the present study we confirm these results and also show by run-on experiments that the decrease in ACE mRNA in the lung is due to a reduction in ACE gene transcription. These changes are concurrent with the pulmonary endothelial dysfunction found in heart failure. As the heart failure syndrome progresses, the blood pressure in the pulmonary circulation increases and shear stress decreases [5] . We previously looked at the effects of stress on ACE expression in vitro and showed that diminished shear stress led to a decrease in ACE mRNA expression and activity [14] . The ACE activity in the lung tissue was negatively correlated with the LVEDD/BW ratio, an indicator of the upstream consequences of LV diastolic dysfunction. We now show that the shedding of ACE from the lung tissue is unchanged in CHF rats. However, the solubilized fraction is significantly increased in the lung meaning that despite decreased in ACE gene transcription and expression, the post-translational maintenance of shedding from the pulmonary endothelium probably participates H-00848-2001. R1 13 in the increase of plasma ACE associated with congestive heart failure.
In the present study, we showed that ACE mRNA expression did not change in the remaining viable myocardium in MI rats with respect to infarct severity or with respect to sham operated rats. ACE activity was below detection limits in LV tissue and remained very low and unchanged in the explant supernatants. A number of other studies have looked at ACE expression in the LV following myocardial infarction, both in experimental rat models as well as in the human hearts and have given conflicting results. Passier et al., showed that ACE mRNA expression in rats increased within 5 days post-infarct and subsequently decreased to baseline levels by day 90 [39] . In this same study, they showed however that the ACE activity in the LV was significantly increased by day 7 and remained high through to day 90. The possible reason for this discrepancy is that care was not taken to separate the scar tissue from the rest of the LV, and that scar was probably the predominant source of the measured tissular ACE activity in this experimental situation.
The loss of contractile tissue and the subsequent dilation and remodelling of the LV results in hemodynamic alterations and increased stress-strain forces acting on the infarct scar. Our laboratory previously showed that in the hypertrophied heart (induced by renovascular hypertension) the induction of ACE mRNA and activity was not found in isolated cardiomyocytes, but instead in pooled non-cardiomyotic cells [40] . We have also shown that induction of ACE expression occurs primarily in smooth muscle cells and fibroblasts in response to hemodynamic stress [15] . These observations are in agreement with our current results which indicate that ACE expression and activity are increased only in the scar tissue, principally composed of myofibroblasts [41] . These data are in agreement with a previous study showing a high density of ACE in valve leaflets in the normal rat heart [42] . This tissue is similar to the infarct scar in that it is mainly composed of myofibroblast and is subjected to high hemodynamic stress at each systole [43] . Sun et al. have shown a colocalization of ACE with α-SMA in the scar of MI rats [20] , a result that we confirm in the present study. We also confirm that this expression is concurrent with the accumulation of collagen [3] .
Our study also shows that ACE activity in the scar culture supernatants is correlated with LV systolic dysfunction (represented by EF). The ejection fraction is also correlated with ACE plasma levels. Combined with the H-00848-2001.R1 14 observation that the absolute values of shed ACE activity are increased in decompensated rats, probably due to the increase in the hemodynamically stressed scar area, it appears likely that the scar participates in the observed increased plasma ACE.
Post-infarct remodelling involves not only the scarification of the necrosed tissue, but also the remaining viable myocardium. Small accumulations of collagen remote to the infarct scar can represent up to two-thirds of the total collagen content in the infarcted human heart and it is these accumulations that are believed to be the major component of the adverse structural remodelling found in ischemic cardiomyopathy [44] . Increases in tissular ACE activity in the scar may have an important role in local collagen accumulation as well as that of the surrounding viable myocardium. The importance of local tissue ACE expression is underlined by Higaki et al., who showed that local transfection of human ACE into the LV results in tissue hypertrophy and increased collagen content [45] .
In conclusion, this study shows that there is a shift in ACE mRNA expression and activity from the lung to the infarct scar in experimental HF and this in proportion to the severity of the infarct. The increase in scar tissue occurred in parallel with an augmentation of solubilized ACE, shed from the cell membrane by the action of a zinc metalloprotease. In contrast, despite the decrease in ACE expression, ACE post-translational shedding is maintained in the lung. This increase in ACE shedding from the scar and its maintenance from the lung could be responsible for the increase in plasma ACE activity observed in this experimental model. Therefore the shift of ACE expression in congestive heart failure and its increased level in the plasma, provides evidence of the dual hemodynamic consequences of the increased tensile stress-strain relationship in the scar and decreased shear stress on the pulmonary endothelium. 
